Science behind cisplatin-induced nephrotoxicity in humans:A clinical study

Objective:To investigate the relationship between serum electrolyte changes and cisplatin induced nephrotoxicity.Methods:We collected data from 18 patients undergoing cisplatin chemotherapy including serum electrolytes,creatinine,blood urea nitrogen(BUN) and urine potassium,sodium and pH levels befo...

Full description

Saved in:
Bibliographic Details
Published inAsian Pacific journal of tropical biomedicine Vol. 2; no. 8; pp. 640 - 644
Main Authors Arunkumar, PA, Viswanatha, GL, Radheshyam, N, Mukund, H, Belliyappa, MS
Format Journal Article
LanguageEnglish
Published China Elsevier B.V 01.08.2012
Asian Pacific Tropical Medicine Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective:To investigate the relationship between serum electrolyte changes and cisplatin induced nephrotoxicity.Methods:We collected data from 18 patients undergoing cisplatin chemotherapy including serum electrolytes,creatinine,blood urea nitrogen(BUN) and urine potassium,sodium and pH levels before and after the cisplatin chemotherapy.All the patients had cancer and were treated with 40-50 mg/day cisplatin.Renal injury was assessed by measuring serum electrolytes,creatinine,BUN levels and urine potassium,sodium and pH levels. Results:The five cycles of cisplatin based chemotherapy resulted in hypomagnesia(P=0.029), hypocalcaemia(P=0.001~*),hypophosphatemia(P=0.003*),hypokalemia(P=0.001~*)and increased serum creatinine(P=0.001~*)and BUN(P=0.292~*)levels.In urine analysis,decrease in potassium(P=0.024~*)was found,except potassium there was no significant changes in sodium and urine pH. Conclusions:The present study demonstrates that,acute nephrotoxicity was observed in patients with different types of cancers undergoing cisplatin based chemotherapy due to electrolyte disturbances,when no corrective measures were initiated.
Bibliography:Arunkumar PA;Viswanatha GL;Radheshyam N;Mukund H;Belliyappa MS;Department of Pharmacology,PES College of Pharmacy;Medical Oncology,Curie Centre for Oncology,St.John’s Medical College;Radiation Oncology,Curie Centre for Oncology,St.John’s Medical College
ISSN:2221-1691
2588-9222
DOI:10.1016/S2221-1691(12)60112-9